Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low‐Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison

BACKGROUND. Daratumumab (a human CD38‐directed monoclonal antibody) and pomalidomide (an immunomodulatory drug) plus dexamethasone are both relatively new treatment options for patients with heavily pretreated multiple myeloma. A matching adjusted indirect comparison (MAIC) was used to compare absol...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Van Sanden, Suzy, Ito, Tetsuro, Diels, Joris, Vogel, Martin, Belch, Andrew, Oriol, Albert
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2017
Teme:
Academia‐Pharma Intersect: Hematologic Malignancies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905688/
https://ncbi.nlm.nih.gov/pubmed/29192016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0103
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki